Craft

Jupiter Neurosciences

Revenue

$638 K

FY, 2021

Jupiter Neurosciences Summary

Company Summary

Overview
Jupiter Neurosciences (formerly known as Jupiter Orphan Therapeutics, JOT) is a clinical-stage research and development pharmaceutical company providing a resveratrol platform for the treatment of neuroinflammation. The JOTROL delivery platform that allows resveratrol to be consumed in an oral patented micellar form.
Type
Public
Status
Active
Founded
2015
HQ
Jupiter, FL, US | view all locations
Website
https://jupiterneurosciences.com/
Cybersecurity rating
Sectors

Key People

  • Christer Rosén

    Christer Rosén, Founder, Chairman & CEO

  • Dana Eschenburg Perez
  • Marshall Hayward

    Marshall Hayward, Co-Founder, CSO, and Director

  • Alexander Rosén

    Alexander Rosén, Co-Founder, CAO

LocationsView all

2 locations detected

  • Jupiter, FL HQ

    United States

    1001 north us hwy 1, suite 504

  • Jupiter, FL

    United States

    601 Heritage Dr #139

Jupiter Neurosciences Financials

Summary Financials

Net income (Q3, 2022)
($1.6M)
Cash (Q3, 2022)
$258.6K
EBIT (Q3, 2022)
($1.1M)

Footer menu